It’s not uncommon for political-related posts to garner lots of story comments and social media posts, but MedCity News reader linked and tweeted one post in record numbers this week.
Drs. Kevin Smith and Richard Amerling ruffled some – ok, lots – of feathers with their posts on the “right” to healthcare and how to survive Obamacare. We highlighted one reader’s insightful response to Smith in a follow-up post.
Also this week…
Mobile health company Ginger.io, which builds apps for behavioral health, raised $6.5 million in a round led by Khosla Ventures.
Boston Scientific and Medtronic are poised to gain market share in 2013 if St. Jude Medical pulls its Durata off the market, which at least one analyst says is quite likely.
Which social media platform should you be on? This infographic will point you in the right direction.
Avaxia Biologics received clearance from the FDA to begin clinical trials of its oral drug for inflammatory bowel disease.
Tweets we liked this week.
From the Show Floor: Advanced Imaging Solutions for the Surgical Space bit.ly/YdUxHG
’ GE Healthcare (@GEHealthcare) November 30, 2012
Healthcare startups should listen to passionate, pissed-off doctors wp.me/p2Q4Zi-f
’ Dr. Alexander Flint (@neuroicudoc) November 29, 2012
Why Your New Cancer Biomarker May Never Work: Recurrent Patterns & Remarkable Diversity in Biomarker Failures ow.ly/fIvFv
’ Mike Thompson, MDPhD (@mtmdphd) November 30, 2012
’ Brian Ahier (@ahier) November 26, 2012